Life Sciences»Pharmaceuticals»Therapeutic Area»CNS/Neurology
Central Nervous System Drugs Global Market Report 2018 Including: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-EpilepticsCovering: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG
| Lowest Prices Guaranteed | Length | Publisher | Published Date | SKU |
|---|---|---|---|---|
| from $4,000 | 125 Pages | The Business Research Company | February, 2018 | BRC15586395 |
| Lowest Prices Guaranteed | |
| Price | from $4,000 |
|---|---|
| Length | 125 Pages |
| Publisher | The Business Research Company |
| Published Date | February, 2018 |
| SKU | BRC15586395 |
Table of Contents
Central Nervous System Drugs Global Market Report 2018 Including: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-EpilepticsCovering: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG Table of Contents
The Business Research Company
- 1. Central Nervous System Drugs Market Characteristics
- 2. Central Nervous System Drugs Market Size And Growth
- 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
- 2.1.1. Drivers Of The Market
- 2.1.2. Restraints On The Market
- 2.2. Forecast Market Growth, Value ($ Billion)
- 2.2.1. Drivers Of The Market
- 2.2.2. Restraints On The Market;
- 3. Central Nervous System Drugs Trends And Strategies;
- 4. Pestle Analysis
- 4.1. Political
- 4.2. Economic
- 4.3. Social
- 4.4. Technological
- 4.5. Legal
- 4.6. Environmental;
- 5. Central Nervous System Drugs Market Customer Information;
- 6. Central Nervous System Drugs Market Regional And Country Analysis
- 6.1. Global Central Nervous System Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
- 6.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Region
- 6.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
- 6.4. Global Central Nervous System Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
- 6.5. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Country
- 6.6. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Country
- 7. Central Nervous System Drugs Market Segmentation
- 7.1. Global Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 7.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 8. Central Nervous System Drugs Market Segments
- 8.1.Other CNS drugs
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Other CNS drugs Market, 2017, By Segment, Value ($ Billion)
- 8.2.Anaesthetics
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Anaesthetics Market, 2017, By Segment, Value ($ Billion)
- 8.3.Analgesics
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Analgesics Market, 2017, By Segment, Value ($ Billion)
- 8.4.Anti-Parkinson drugs
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Anti-Parkinson drugs Market, 2017, By Segment, Value ($ Billion)
- 8.5.Anti-Epileptics
- a) Market Characteristics
- b) Market Trends & Strategies
- c) Global Anti-Epileptics Market, 2017, By Segment, Value ($ Billion)
- 9. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors
- 9.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
- 9.2. Per Capita Average Central Nervous System Drugs Expenditure, Global
- 10. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries
- 10.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country
- 10.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country
- 11. Central Nervous System Drugs Market Comparison With Industry Metrics
- 11.1. Global Number Of Pharmacists, 2017, By Country
- 11.2. Global Central Nervous System Market Revenue Versus Number Of Pharmacists, 2017, By Country
- 11.3. Global Number Of Pharma Enterprises, 2017, By Country
- 11.4. Global Central Nervous System Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
- 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
- 11.6. Global Central Nervous System Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
- 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
- 11.8. Global Central Nervous System Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
- 11.9. Prevalent Cases Of Parkinsons Disease, 2014, By Country
- 11.10. Global Number Of Psychiatrists, 2017, By Country
- 11.11. Global Central Nervous System Market Revenue Versus Number Of Psychiatrists, 2017, By Country
- 11.12. Global Number Of General Practitioners 2017, By Country
- 11.13. Global Central Nervous System Market Revenue Versus Number Of General Practitioners, 2017, By Country
- 12. Asia-Pacific Central Nervous System Drugs Market
- 12.1.1. Asia-Pacific Central Nervous System Drugs Market Overview
- 12.1.2. Asia-Pacific Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.1.3. Asia-Pacific Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.1.4. Asia-Pacific Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 12.1.5. Asia-Pacific Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.2. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
- 12.3. China Central Nervous System Drugs Market
- 12.3.1. China Central Nervous System Drugs Market Overview
- 12.3.2. China Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.3.3. China Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.3.4. China Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 12.3.5. China Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.4. India Central Nervous System Drugs Market
- 12.4.1. India Central Nervous System Drugs Market Overview
- 12.4.2. India Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.4.3. India Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.4.4. India Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 12.4.5. India Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.5. Japan Central Nervous System Drugs Market
- 12.5.1. Japan Central Nervous System Drugs Market Overview
- 12.5.2. Japan Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.5.3. Japan Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.5.4. Japan Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 12.5.5. Japan Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 12.6. Australia Central Nervous System Drugs Market
- 12.6.1. Australia Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 12.6.2. Australia Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 12.6.3. Australia Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 12.6.4. Australia Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13. Western Europe Central Nervous System Drugs Market
- 13.1.1. Western Europe Central Nervous System Drugs Market Overview
- 13.1.2. Western Europe Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.1.3. Western Europe Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.1.4. Western Europe Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 13.1.5. Western Europe Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.2. Western Europe Central Nervous System Drugs Market: Country Analysis
- 13.3. UK Central Nervous System Drugs Market
- 13.3.1. UK Central Nervous System Drugs Market Overview
- 13.3.2. UK Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.3.3. UK Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.3.4. UK Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 13.3.5. UK Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.4. Germany Central Nervous System Drugs Market
- 13.4.1. Germany Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.4.2. Germany Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.4.3. Germany Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 13.4.4. Germany Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.5 France Central Nervous System Drugs Market
- 13.5.1 France Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.5.2 France Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.5.3. France Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 13.5.4. France Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.6. Italy Central Nervous System Drugs Market
- 13.6.1. Italy Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.6.2. Italy Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.6.3. Italy Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 13.6.4. Italy Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 13.7. Spain Central Nervous System Drugs Market
- 13.7.1. Spain Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 13.7.2. Spain Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 13.7.3. Spain Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 13.7.4. Spain Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 14. Eastern Europe Central Nervous System Drugs Market
- 14.1.1. Eastern Europe Central Nervous System Drugs Market Overview
- 14.1.2. Eastern Europe Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 14.1.3. Eastern Europe Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 14.1.4. Eastern Europe Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 14.1.5. Eastern Europe Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 14.2. Eastern Europe Central Nervous System Drugs Market: Country Analysis
- 14.3. Russia Central Nervous System Drugs Market
- 14.3.1. Russia Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 14.3.2. Russia Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 14.3.3. Russia Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 14.3.4. Russia Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 15. North America Central Nervous System Drugs Market
- 15.1.1. North America Central Nervous System Drugs Market Overview
- 15.1.2. North America Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 15.1.3. North America Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 15.1.4. North America Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 15.1.5. North America Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 15.2. North America Central Nervous System Drugs Market: Country Analysis
- 15.3. USA Central Nervous System Drugs Market
- 15.3.1. USA Central Nervous System Drugs Market Overview
- 15.3.2. USA Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 15.3.3. USA Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 15.3.4. USA Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 15.3.5. USA Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 16. South America Central Nervous System Drugs Market
- 16.1.1. South America Central Nervous System Drugs Market Overview
- 16.1.2. South America Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 16.1.3. South America Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 16.1.4. South America Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 16.1.5. South America Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 16.2. South America Central Nervous System Drugs Market: Country Analysis
- 16.3. Brazil Central Nervous System Drugs Market
- 16.3.1. Brazil Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 16.3.2. Brazil Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 16.3.3. Brazil Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 16.3.4. Brazil Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 17. Middle East Central Nervous System Drugs Market
- 17.1.1. Middle East Central Nervous System Drugs Market Overview
- 17.1.2. Middle East Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 17.1.3. Middle East Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 17.1.4. Middle East Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 17.1.5. Middle East Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 18. Africa Central Nervous System Drugs Market
- 18.1.1. Africa Central Nervous System Drugs Market Overview
- 18.1.2. Africa Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
- 18.1.3. Africa Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
- 18.1.4. Africa Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
- Other CNS drugs
- Anaesthetics
- Analgesics
- Anti-Parkinson drugs
- Anti-Epileptics
- 18.1.5. Africa Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
- 19. Central Nervous System Drugs Market Competitive Landscape
- 19.1. Company Profiles
- 19.2. Biogen Inc
- 19.2.1. Overview
- 19.2.2. Products And Services
- 19.2.3. Strategy
- 19.2.4. Financial Performance
- 19.3. F. Hoffmann-La Roche Ltd
- 19.3.1. Overview
- 19.3.2. Products And Services
- 19.3.3. Strategy
- 19.3.4. Financial Performance
- 19.4. Johnson & Johnson
- 19.4.1. Overview
- 19.4.2. Products And Services
- 19.4.3. Strategy
- 19.4.4. Financial Performance
- 19.5. Pfizer Inc
- 19.5.1. Overview
- 19.5.2. Products And Services
- 19.5.3. Strategy
- 19.5.4. Financial Performance
- 19.6. Novartis AG
- 19.6.1. Overview
- 19.6.2. Products And Services
- 19.6.3. Strategy
- 19.6.4. Financial Performance
- 20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
- 21. Market Background: Central Nervous System Drugs Market
- 21.1.1. Central Nervous System Drugs Market Characteristics
- 21.1.2. Central Nervous System Drugs Market Historic Growth, Value ($ Billion)
- 21.1.2.1. Drivers Of The Market
- 21.1.2.2. Restraints Of The Market
- 21.1.3. Central Nervous System Drugs Market Forecast Growth, Value ($ Billion)
- 21.1.3.1. Drivers Of The Market
- 21.1.3.2. Restraints Of The Market
- 21.1.4. Central Nervous System Drugs Trends And Strategies
- 21.2. Central Nervous System Drugs Market Regional And Country Analysis
- 21.2.1. Global Central Nervous System Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
- 21.2.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Region
- 21.2.3. Central Nervous System Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
- 21.2.4. Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Country
- 21.2.5. Central Nervous System Drugs Market, Growth And Market Share Comparison, By Segment
- 21.2.6. Central Nervous System Drugs Market, Growth And Market Share Comparison, By Country And Segment
- 21.3. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors
- 21.3.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
- 21.3.2. Per Capita Average Central Nervous System Drugs Expenditure, Global
- 21.4. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries
- 21.4.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country
- 21.4.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country
- 21.5. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
- 22. Appendix
- 22.1. NAICS Definitions Of Industry Covered In This Report
- 22.2. Abbreviations
- 22.3. Currencies
- 22.4. Research Inquiries
- 22.5. The Business Research Company
- 22.6. Copyright And Disclaimer
Description
Central Nervous System Drugs Global Market Report 2018 Including: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-EpilepticsCovering: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG Description
The Business Research Company
Central Nervous System Drugs Global Market Report 2018 Including: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-EpilepticsCovering: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG
Central Nervous System Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The central nervous system drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Central Nervous System Drugs Indicators Comparison.
Scope
Markets Covered: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-Epileptics
Companies Mentioned: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Central Nervous System Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
| PDF E-mail From Publisher | $4,000 | |
|---|---|---|
| Site License Fulfilled By Publisher | $6,000 | |
| Global Site License Fulfilled by Publisher | $8,000 |
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
